Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

US Army
US Department of Justice
Covington
Mallinckrodt
Healthtrust
Harvard Business School

Generated: July 17, 2019

DrugPatentWatch Database Preview

Patent: 8,815,237

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,815,237
Title:Aglycosylated immunoglobulin mutants
Abstract: The present invention is based, in part, on our discovery of immunoglobulins (e.g., immunoglobulin G (IgG)) polypeptides (e.g., murine or human IgG, such as human IgG1) that are aglycosylated yet retain the ability to bind to an Fc receptor, such as an activating Fc receptor (e.g., Fc.gamma.RIIA and/or Fc.gamma.RIIIA).
Inventor(s): Wittrup; K. Dane (Chestnut Hill, MA), Ravetch; Jeffrey (New York, NY), Sazinsky; Stephen Lael (Brookline, MA)
Assignee: Massachusetts Institute of Technology (Cambridge, MA) The Rockefeller University (New York, NY)
Application Number:12/746,411
Patent Claims:see list of patent claims

Details for Patent 8,815,237

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up Massachusetts Institute of Technology (Cambridge, MA) The Rockefeller University (New York, NY) ➤ Sign Up RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up Massachusetts Institute of Technology (Cambridge, MA) The Rockefeller University (New York, NY) ➤ Sign Up RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up Massachusetts Institute of Technology (Cambridge, MA) The Rockefeller University (New York, NY) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
McKesson
Mallinckrodt
QuintilesIMS
Chubb
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.